Azienda Ulss 2 Marca Trevigiana
Clinical trials sponsored by Azienda Ulss 2 Marca Trevigiana, explained in plain language.
-
88% of patients with asthma and nasal polyps achieve dual remission on dupilumab
Disease control CompletedThis study looked at 28 adults with both severe asthma and chronic sinusitis with nasal polyps who were treated with dupilumab for 24 months. The goal was to see if the drug could help control both conditions at the same time, called 'dual remission.' After 24 months, 88% of pati…
Sponsor: Azienda Ulss 2 Marca Trevigiana • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Yoga and body therapy show promise for eating disorder recovery
Symptom relief CompletedThis study tested whether adding weekly yoga or a special body-focused therapy (FSB) to standard care helps young women aged 16–25 with eating disorders like anorexia or bulimia. 54 participants were split into three groups: standard care only, standard care plus yoga, or standar…
Phase: NA • Sponsor: Azienda Ulss 2 Marca Trevigiana • Aim: Symptom relief
Last updated Jun 05, 2026 12:06 UTC